ES2123010T3 - Inhibidor del estrechamiento vascular utilizando anticuerpos anti-padgem. - Google Patents

Inhibidor del estrechamiento vascular utilizando anticuerpos anti-padgem.

Info

Publication number
ES2123010T3
ES2123010T3 ES92922039T ES92922039T ES2123010T3 ES 2123010 T3 ES2123010 T3 ES 2123010T3 ES 92922039 T ES92922039 T ES 92922039T ES 92922039 T ES92922039 T ES 92922039T ES 2123010 T3 ES2123010 T3 ES 2123010T3
Authority
ES
Spain
Prior art keywords
padgem
inhibitor
vascular closure
intravascular
vascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92922039T
Other languages
English (en)
Inventor
Theresa M Palabrica
Bruce E Furie
Barbara C Furie
Roy R Lobb
Christopher D Benjamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New England Medical Center Hospitals Inc
Biogen Inc
Original Assignee
New England Medical Center Hospitals Inc
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Hospitals Inc, Biogen Inc filed Critical New England Medical Center Hospitals Inc
Application granted granted Critical
Publication of ES2123010T3 publication Critical patent/ES2123010T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE EXPONE UN METODO PARA INHIBIR ESTRECHAMIENTO VASCULAR EN UN LUGAR INTRAVASCULAR POR ANGIOPLASTIA, ENDOARTERECTOMIA O ATEROECTOMIA EN INJERTOS VASCULARES NATURALES O SINTETICOS, EN FISTULAS ARTERIOVENOSAS, EN LUGARES INTRAVASCULARES SIGUIENTES A LA EXTENSION DE MALLAS VASCULARES O DISPOSITIVOS CARDIOVASCULARES, Y EN UN LUGAR INTRAVASCULAR DE DEPOSICION DE PLAQUETAS. EL METODO COMPRENDE EL PASO DE ADMINISTRAR UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE UN ANTICUERPO ANTI-PADGEM O UN ANTICUERPO HOMOLOGO DE EL QUE ENLAZA PADGEM.
ES92922039T 1991-09-30 1992-09-30 Inhibidor del estrechamiento vascular utilizando anticuerpos anti-padgem. Expired - Lifetime ES2123010T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76883491A 1991-09-30 1991-09-30

Publications (1)

Publication Number Publication Date
ES2123010T3 true ES2123010T3 (es) 1999-01-01

Family

ID=25083621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92922039T Expired - Lifetime ES2123010T3 (es) 1991-09-30 1992-09-30 Inhibidor del estrechamiento vascular utilizando anticuerpos anti-padgem.

Country Status (9)

Country Link
EP (1) EP0606391B1 (es)
JP (1) JPH07502726A (es)
AT (1) ATE169227T1 (es)
AU (1) AU678757B2 (es)
CA (1) CA2120240A1 (es)
DE (1) DE69226531T2 (es)
DK (1) DK0606391T3 (es)
ES (1) ES2123010T3 (es)
WO (1) WO1993006863A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
CA2175214A1 (en) * 1993-11-05 1995-05-11 Barry S. Coller Platelet-specific chimeric immunoglobulin and methods of use therefor
AU2305201A (en) * 1993-11-05 2001-05-03 Centocor Inc. Platelet-specific chimeric immunoglobulin and methods of use therefor
EP1714661A3 (en) * 2000-05-19 2012-03-14 The Center for Blood Research, INC. Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
CA2408883A1 (en) 2000-05-19 2001-11-29 The Center For Blood Research, Inc. Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
KR100891620B1 (ko) 2004-04-13 2009-04-02 에프. 호프만-라 로슈 아게 항-ｐ-셀렉틴 항체
US20110212096A1 (en) 2006-12-01 2011-09-01 Scott Rollins Anti-p-selectin antibodies and methods of their use and identification
EP2662091B1 (en) 2006-12-01 2018-08-22 Selexys Pharmaceuticals Corporation Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
AU2009294680A1 (en) 2008-09-19 2010-03-25 F. Hoffmann-La Roche Ag Novel antibody formulation
US20200087403A1 (en) 2017-03-15 2020-03-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions for the treatment of thrombosis in patients suffering from a myeloproliferative neoplasm
US20200200774A1 (en) 2017-06-20 2020-06-25 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for identifying whether patients with acute decompensated heart failure (adhf) exhibit a hypercoagulable state

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001380A1 (fr) * 1989-07-25 1991-02-07 Institut National De La Sante Et De La Recherche Medicale Anticorps monoclonaux diriges contre des proteines impliquees dans les fonctions plaquettaires, leur application en tant qu'agent diagnostique et therapeutique
JPH05504470A (ja) * 1989-10-20 1993-07-15 ニューイングランド・メディカル・センター・ホスピタルズ・インコーポレーテッド Ｐａｄｇｅｍを介した細胞結合の阻害
WO1991007993A1 (en) * 1989-11-30 1991-06-13 Mathew Vadas Anti-inflammatory and anti-adhesive factors

Also Published As

Publication number Publication date
EP0606391B1 (en) 1998-08-05
JPH07502726A (ja) 1995-03-23
WO1993006863A1 (en) 1993-04-15
DE69226531T2 (de) 1999-05-06
EP0606391A1 (en) 1994-07-20
AU2869492A (en) 1993-05-03
AU678757B2 (en) 1997-06-12
CA2120240A1 (en) 1993-03-31
DE69226531D1 (de) 1998-09-10
ATE169227T1 (de) 1998-08-15
DK0606391T3 (da) 1999-05-03

Similar Documents

Publication Publication Date Title
ES2123010T3 (es) Inhibidor del estrechamiento vascular utilizando anticuerpos anti-padgem.
HK1225741A1 (zh) 用於治療和預防異種移植或急性血管排斥反應的補體c5激活的抑制
ATE324866T1 (de) Verfahren zur behandlung von gefässrestenose durch inhalieren von stickoxid
MY111961A (en) Therapeutic method
NZ511956A (en) Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
ATE196849T1 (de) Verfahren zur behandlung von multiplesklerose
ATE151078T1 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
GB0031448D0 (en) Inhibition of the vWF-collagen interaction by anti-human vWF monoclonal antibody (82D6A3) results in abolition of in vivo arterial platelet thrombus formation
FI955261A (fi) P-selektiinin vasta-aineita ja niiden käyttö
KR970701063A (ko) 안티트롬빈제 용도로써 피브린-특이적 항체(fibrin-specific antibody for use as an antithrombotic agent)
ES2122248T3 (es) Inhibicion de la hiperplasia de la intima que emplea anticuerpos de receptores del factor de crecimiento derivado de plaquetas.
DE69232579T2 (de) Anti-Plättchen-Wachstumsfaktor-Antikörper in der Behandlung von Restenose
ES2123597T3 (es) Construcciones de anticuerpos que se unen a granulocitos, su preparacion y empleo.
Azrin et al. Preparation, characterization, and evaluation of a monoclonal antibody against the rabbit platelet glycoprotein IIb/IIIa in an experimental angioplasty model.
RU96112183A (ru) Тромбоцит - специфичный химерный иммуноглобулин и методы его использования
DE69025629T2 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids-verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
FR2697154B1 (fr) Perfectionnement au composant fémoral des prothèse du genou.
UA37249C2 (uk) Спосіб інгібування стенозу та/або рестенозу (варіанти), спосіб інгібування рестенозу після проведення операції на коронарній артерії у людини (варіанти), спосіб зниження ймовірності виникнення чи запобігання негострих ішемічних ускладнень при ангіопластиці у людини
MY115415A (en) Medicaments.
DE69012034D1 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
GEP20043233B (en) Composition Containing Blocking Monoclonal Antibody VLA-1
ITMI930585A1 (it) Catetere per la chiusura endovenosa del reflusso safeno femorale

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 606391

Country of ref document: ES